Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss

Executive Summary

While Mylan wants Autor to help push quality improvement efforts around the world, her departure from FDA may affect implementation of similar plans at the agency.

You may also be interested in...



Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry

Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.

Mylan Grabs More FDA Globalization Talent

Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.

Mylan Grabs More FDA Globalization Talent

Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel